<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 17:12:50" record="37309" source="Espacenet">
	<entities>
		<entity ref="Patent37309" type="Patent">
			<semanticIdentifier>brcris::e31a7afdc0d1cf55e5c5c35aec021dd9</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0705126A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BRPI0705126</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0705126A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR2007PI05126</semanticIdentifier>
			<semanticIdentifier>original::PIPI 0705126-3</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=PI0705126"/>
			<field name="identifier.lattes" value="5014918663341911"/>
			<field name="identifier.espacenet" value="PI0705126"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="formulação farmacêutica para uso parenteral de compostos derivados de metotrexato associados a ésteres de colesterol"/>
			<field name="title.lattes" value="Formulação farmacêutica para uso parenteral de composto derivadores de metotrexato associados a ésteres de colesterol"/>
			<field name="depositDate" value="2007-10-09"/>
			<field name="publicationDate" value="2009-06-16"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="RAUL CAVALCANTE MARANHAO"/>
			<field name="inventor" value="RAUL CAVALCANTE MARANHAO"/>
			<field name="applicant" value="FUNDACAO ZERBINI"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/519AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="519AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K9/107AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="107AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K9/127AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="127AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P17/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="17"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P19/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="19"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="6"/>
				<field name="text" value="A61P37/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="37"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="FORMULAçãO FARMACêUTICA PARA USO PARENTERAL DE COMPOSTOS DERIVADOS DE METOTREXATO ASSOCIADOS A éSTERES DE COLESTEROL. Formulação farmacêutica esta que compreende uma emulsão de compostos derivatizados de metotrexato associados a ésteres de colesterol e fosfolípides numa faixa de 1:2 até 2:1 (peso:peso) em tampão farmaceuticamente aceitável na faixa de pH de 7,4 a 8,05, e um tensoativo na faixa de 8 mg/mL a 12 mg/mL, para uso parenteral no tratamento das doenças de caráter inflamatório crónico como a aterosclerose, artrites, psoríase, no manejo medicamentoso de pacientes pós-transplante de órgãos e no tratamento do câncer."/>
			<field name="originatesFrom" value="40748425"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0705126"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BRPI0705126"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0705126"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR2007PI05126"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value="PI"/>
				<field name="number" value="PI 0705126-3"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person25735" type="Person">
			<semanticIdentifier>lattes::5014918663341911</semanticIdentifier>
			<field name="identifier.lattes" value="5014918663341911"/>
			<field name="name" value="Raul Cavalcante Maranhao"/>
		</entity>
		<entity ref="OrgUnit20202" type="OrgUnit">
			<semanticIdentifier>brcris::8109235aad882306ec90d66a5c715818</semanticIdentifier>
			<field name="name" value="FUNDACAO ZERBINI"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent37309" toEntityRef="Person25735" type="Inventor"/>
		<relation fromEntityRef="Patent37309" toEntityRef="OrgUnit20202" type="Applicant"/>
	</relations>
</entity-relation-data>
